Your browser doesn't support javascript.
loading
Doxorubicin: Comparison between 3-h continuous and bolus intravenous administration paradigms on cardio-renal axis, mitochondrial sphingolipids and pathology.
Kamendi, Harriet; Zhou, Ying; Crosby, Meredith; Keirstead, Natalie; Snow, Debra; Bentley, Patricia; Patel, Nilaben; Barthlow, Herbert; Luo, Wenli; Dragan, Yvonne; Bialecki, Russell.
Afiliação
  • Kamendi H; Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: harriet_kamendi@kandih.com.
  • Zhou Y; Oncology Innovative Medicines and Early Development, AstraZeneca, Waltham, MA 02451, USA. Electronic address: yingzhou526@gmail.com.
  • Crosby M; Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Meredith.crosby@astrazeneca.com.
  • Keirstead N; Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Nkeirstead@alnylam.com.
  • Snow D; Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Debra.snow@astrazeneca.com.
  • Bentley P; Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: patricia.bentley@abbvie.com.
  • Patel N; Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: patelnilaben@yahoo.com.
  • Barthlow H; Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Herbert.barthlow@astrazeneca.com.
  • Luo W; Discovery Sciences, Innovative Medicines, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Wenli.luo@astrazeneca.com.
  • Dragan Y; Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Yvonne.P.Dragan@takeda.com.
  • Bialecki R; Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: russell.bialecki@astrazeneca.com.
Toxicol Appl Pharmacol ; 289(3): 560-72, 2015 Dec 15.
Article em En | MEDLINE | ID: mdl-26450648

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esfingolipídeos / Doxorrubicina / Coração / Rim / Mitocôndrias Limite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esfingolipídeos / Doxorrubicina / Coração / Rim / Mitocôndrias Limite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2015 Tipo de documento: Article